High body burdens of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) in California women. by Petreas, Myrto et al.
Persistent organic pollutants (POPs) enter the
natural environment via a multitude of path-
ways. Body burdens reﬂect cumulative expo-
sures to such chemicals and can be used to
assess temporal and spatial trends. Body bur-
dens of organochlorine compounds [polychlo-
rinated dibenzo-p-dioxins, polychlorinated
biphenyls (PCBs), pesticides] are declining in
most of the industrialized countries (Liem et
al. 1995; Noren and Meironyte 1998, 2000;
Smith 1999) as a result of source reduction
measures. Polybrominated diphenyl ethers
(PBDEs), on the other hand, show increasing
trends worldwide (de Wit 2002). Three indus-
trial formulations of PBDEs are used widely as
flame retardants [Bromine Science and
Environmental Forum (BSEF) 2001]. Deca-
BDE (consisting almost completely of BDE-
209) is used mainly in thermoplastics and
textiles. In 1999, its use in the United States
was estimated at 25,000 metric tons, or 44%
of its global use (Hale et al. 2002). Octa-BDE
(a mixture of hexa- to octa-BDE congeners) is
used in acrylonitrile/butadiene/styrene (ABS)
plastics. Its use in the United States was esti-
mated at 1,400 metric tons in 1999, corre-
sponding to about 36% of its global use (Hale
et al. 2002). Penta-BDE (a mixture of tetra-
and penta-BDE congeners) is used mainly in
polyurethane foam. The U.S. market used
about 8,000 metric tons in 1999, which is
approximately 98% of the global production
of penta-BDE (Hale et al. 2002). Although the
more brominated formulations are used more
extensively worldwide than is penta-BDE, the
tetra- and penta-congeners bioaccumulate to a
greater degree than do the higher homologues
(World Health Organization 1994). In fact,
the congener pattern found in biota closely
matches the pattern of the penta-BDE for-
mulation (Hale et al. 2002), with 2,2´,4,4´-
tetrabromodiphenyl ether (BDE-47) as a
dominant congener. Production of all PBDEs
has increased over the last 20 years, accompa-
nied by their emergence in environmental and
biologic samples (de Boer et al. 1998; de Wit
2002). Hepatotoxicity, embryotoxicity, thy-
roid, and behavioral effects have been reported
in animal studies (Darnerud et al. 2001;
McDonald 2002). Of particular concern is
the ability of PBDEs to disrupt thyroid hor-
mone balance and to cause behavioral and
learning deﬁcits in rodents exposed in utero or
postnatally (Eriksson et al. 2001). Elevated
PBDE body burdens in women of childbear-
ing age could therefore be an important public
health issue.
Concentrations (mean, 86 ng/g lipid) of
ΣPBDEs (sum of BDE-47, BDE-99,
BDE-100, BDE-153, and BDE-154) in adi-
pose tissues from a group of 23 California
women (She et al. 2002) appear to be 3–10
times higher than concentrations reported
from other parts of the world (Darnerud et al.
1998; de Wit 2002; Noren and Meironyte
2000; Ohta et al. 2002; Ryan and Patry 2000;
Schroeter-Kermani et al. 2000). In addition,
concentrations in archived blubber from San
Francisco Bay harbor seals demonstrate a 100-
fold increase over the last decade (She et al.
2002). In this article, we report on additional
PBDE measurements in adipose and serum
from diverse groups of California women, in
an effort to better understand sources and
pathways leading to the observed high levels.
Materials and Methods
Subjects. The PBDE analyses were performed
on adipose and serum samples collected in the
course of three separate epidemiologic studies.
All three studies involved women living in the
San Francisco Bay Area of California.
Adipose from the late 1990s. Breast adi-
pose samples from a group of 32 women, resi-
dents of the San Francisco Bay Area, were
analyzed for PBDEs. This group was a ran-
dom subsample from a case–control study on
breast cancer and organochlorine exposures
(Petreas et al. 2000), and it included women
with malignancies, ductal carcinoma in situ,
and benign breast disease. Participants of the
original case–control study were recruited
among women undergoing biopsies or
lumpectomies at Stanford University Hospital
or Kaiser-Oakland Hospital (both in the gen-
eral San Francisco Bay Area). Eligibility crite-
ria included age between 25 and 65 years, no
prior cancer, and not taking tamoxifen or
undergoing chemotherapy. Breast adipose tis-
sue (~1 g) was collected during biopsy or
Environmental Health Perspectives • VOLUME 111 | NUMBER 9 | July 2003 1175
High Body Burdens of 2,2´,4,4´-Tetrabromodiphenyl Ether (BDE-47) in
California Women
Myrto Petreas,1 Jianwen She,1 F. Reber Brown,1 Jennifer Winkler,1,2 Gayle Windham,3 Evan Rogers,2,4
Guomao Zhao,2,4 Rajiv Bhatia,5 and M. Judith Charles4
1Hazardous Materials Laboratory, Department of Toxic Substances Control, California Environmental Protection Agency, Berkeley,
California, USA; 2Public Health Institute, Berkeley, California, USA; 3Environmental Health Investigations Branch, Department of Health
Services, Oakland, California, USA; 4Department of Environmental Toxicology, University of California, Davis, California, USA; 5San
Francisco Department of Public Health, San Francisco, California, USA
Address correspondence to M. Petreas, Hazardous
Materials Laboratory, California EPA, 2151 Berkeley
Way, Berkeley, CA 94704 USA. Telephone: (510)
540-3624. Fax: (510) 540-2305. E-mail: mpetreas@
dtsc.ca.gov
We thank all participants. The breast adipose sam-
ples were collected by S. Jeffrey and M.E. Mahoney of
Stanford University Hospital and K. O’Neal of Kaiser
Oakland Hospital, as part of a breast cancer study con-
ducted in collaboration with P. Reynolds, D. Smith,
and D. Gilliss of the California Department of Health
Services.
The breast cancer study was partially funded by the
U.S. Department of the Army (DAMD-17-94-J-4429)
and by the California Breast Cancer Research Program
(grant 2RB-0054). The Laotian reproductive study was
funded by the National Institute of Environmental
Health Sciences (NIEHS) (5 R01 ES08324-04), and
data collection was managed by D. Lee and D. Epstein
of the California Department of Health Services. The
study of male genital birth defects using archived serum
was funded by the NIEHS (5 R01 ES009042-06).
The authors declare they have no conﬂict of interest.
Received 17 January 2003; accepted 10 March 2003.
Following our ﬁrst report on elevated polybrominated diphenyl ether (PBDE) concentrations in
California women, we expanded our investigation to include diverse groups of local women. We
analyzed additional adipose and serum samples collected in the late 1990s from San Francisco Bay
Area women participating in a breast cancer study and in a reproductive study, respectively. Adipose
samples (n = 32) were analyzed by low-resolution mass spectrometry in negative-ion chemical ion-
ization mode, whereas serum samples (n = 50) were analyzed by dual-column gas chromatography
with electron capture detection. The results confirmed our earlier findings. Concentrations of
2,2´,4,4´-tetrabromodiphenyl ether (BDE-47) in contemporary California women ranged between
5 and 510 ng/g lipid, with a median (16.5 ng/g lipid) 3–10 times higher than those reported from
Europe. In contrast, PBDEs were not measurable in any of 420 archived serum samples collected in
the 1960s from San Francisco Bay Area women participating in a study of child development.
BDE-47 concentrations did not increase with age or with concentrations of a polychlorinated
biphenyl (PCB-153), suggesting other routes of exposure in addition to diet. Rising body burdens
of endocrine-disrupting chemicals such as PBDEs may pose a potential public health threat. Key
words: adipose tissue, BDE-47, body burdens, California, PBDEs, persistent organic pollutants,
polybrominated diphenyl ethers, serum, time trends. Environ Health Perspect 111:1175–1179
(2003). doi:10.1289/ehp.6220 available via http://dx.doi.org/ [Online 10 March 2003]
Research | Articlebreast surgery between 1996 and 1998 and
archived at –20°C until analysis. The group of
women discussed in this study includes the 23
women whose PBDE concentrations have
already been reported (She et al. 2002).
Serum from the late 1990s. Between 1997
and 1999, blood was collected from a group of
50 Laotian immigrant women who lived in the
San Francisco Bay Area and were participating
in a study of organochlorine exposures and
menstrual cycle function (Windham et al.
2002). Convenience sampling was used with
trained Laotian community field workers,
recruiting participants from Asian markets,
cultural events, friends, health clinics, and
English language classes. Eligibility criteria
included reproductive age (19–40 years),
recent menstrual period, birth in Southeast
Asia, and regular consumption of ﬁsh. Blood
was drawn at a local clinic and serum was sepa-
rated and archived at –20°C until analysis.
Serum from the early 1960s. For a his-
toric comparison population, archived serum
was obtained from a case–control study of
cryptorchidism and hypospadias and in utero
exposure to organochlorine pesticides (OCPs)
nested within the historic Child Health and
Development Studies (CHDS) cohort. The
CHDS (van den Berg 1979), a longitudinal
study of 20,000 pregnancies among Northern
California Kaiser Foundation Health Plan
members, enrolled subjects between 1959 and
1966, a time of unrestricted use of PCBs and
OCPs. Mothers were followed during preg-
nancy, and multiple samples of serum from
each pregnancy were collected and archived.
A subset of these children was followed for
subsequent follow-up examinations. Subjects
selected for this study included 155 male
infants with hypospadias or cryptorchidism
and surviving for 2 years, as well as twice that
number of randomly selected controls.
Maternal serum from the second or third
trimesters of pregnancy was retrieved from
archived frozen samples stored at the National
Cancer Institute (Frederick, MD). Serum from
420 women was available for this comparison.
Analytical methods. Serum and adipose
samples were kept frozen below –20°C until
analysis. Serum was thawed, and 1 mL was
pipetted into a 15-mL test tube. Internal stan-
dards [PCB congeners 14, 65, and 166 and
tetrachloro-m-xylene (TCMX)] were added
before denaturing the proteins with 1 mL
acetic acid (California Department of Toxic
Substances Control 2003). The analytes in the
serum were then extracted four times with 3
mL hexane/dichloromethane (90:10, vol/vol),
and the extract was passed through a glass col-
umn (15 × 250 mm) ﬁlled with 11.5 g Florisil.
The Florisil was baked at 575°C for 4–6 hr,
deactivated with distilled HPLC-grade water,
and conditioned with 6 mL hexane before use.
The analytes were eluted with 60 mL hexane
followed by 6 mL hexane/dichloromethane
(1:1, vol/vol) The eluates were combined and
reduced to 75 µL. Twenty-ﬁve microliters of a
61.9 pg/µL solution of the recovery standards
[pentachloronitrobenzene (PCNB), PCB-30,
PCB-204, and PCB-209] were added to the
extract to achieve a ﬁnal concentration of 15.5
pg/µL. Calibration solutions ranged in concen-
tration from about 0.2 pg/µL to 50 pg/µL of
BDE-47 and 15.5 pg/µL of PCNB, PCB-30,
PCB-204, and PCB-209. Analysis was per-
formed by gas chromatography/electron cap-
ture detection (GC/ECD) equipped with
60-m DB-XLB (Agilent Technologies,
Wilmington, DE) and Rtx-5ms (Restek
Corporation, Bellefonte, PA) capillary GC
columns. In previous work (James et al. 2002),
60-m DB-17 and Rtx-5ms columns were used
to provide congener separation of the PCBs.
However, in this project, we discovered that
using the combination of DB-XLB and Rtx-
5ms columns provided better resolution of the
PCB congeners. By using a long temperature
program, the retention time of BDE-47
exceeded the retention time of most PCBs. 
Quantitation for BDE-47 was accom-
plished by using the data obtained on the
DB-XLB column. The serum samples were
processed in batches of nine. With each
batch, we processed 1 mL HPLC-grade water
(reagent blank) and 1 mL bovine serum forti-
ﬁed with BDE-47 (among other analytes) to
evaluate background contributions from the
reagents, precision, and analyte recovery. In
addition, samples of pooled human serum
were interspersed blindly among the samples
(for quality control) to assess accuracy and
precision across all serum batches. Total cho-
lesterol and triglycerides were determined
enzymatically in a small aliquot of serum at
the Clinical and Epidemiological Research
Laboratory, Boston Children’s Hospital
(Boston, MA). Total lipids were calculated
from total cholesterol and triglycerides as
described by Phillips et al. (1989), and results
were reported as nanograms per gram lipid.
As described in detail previously (She et al.
2002), adipose samples were homogenized
and internal standards were added, including
13C12-labeled BDE-77. Although we could
have used unlabeled standards for this work,
13C12-labeled BDE-77 allowed us a compari-
son of instrumental techniques (not reported
here). Samples were extracted with 1:1
hexane:dichloromethane, and PBDEs were iso-
lated by passing the extract through a gel per-
meation chromatographic column and a glass
column packed with Florisil in a single auto-
mated step (FMS, Waltham, MA). The extracts
were concentrated and recovery standards
added (13C12-PCB-128, 13C12-PCB-178, and
13C6 α-hexachlorocyclohexane). BDE-47,
BDE-99, BDE-100, BDE-153, and BDE-154
were analyzed by low resolution mass spec-
trometry (Finnigan 4510; Finnigan MAT, San
Jose, CA) in the negative ion chemical ioniza-
tion mode using a DB-5ms column (60 m,
0.25 mm inner diameter, 0.25 µm ﬁlm thick-
ness; J&W Scientiﬁc, Folsom, CA). Methane
was used as the reagent gas; the ion source
pressure was 0.6 Torr, and the ion source tem-
perature was 100°C. The electron energy was
typically 70 eV, and the electron current was
kept at 0.3 mA. We monitored m/z 79 and
81, corresponding to bromide. Adipose sam-
ples were analyzed in batches of six, with a
reagent blank per batch. Samples of certiﬁed
reference material (SRM 1945, whale blub-
ber; National Institute of Standards and
Technology, Gaithersburg, MD) were ana-
lyzed to assess accuracy and precision. Lipid
content of the adipose samples was deter-
mined gravimetrically in an aliquot of the
extract, and PBDE results were reported as
nanograms per gram lipid.
Statistical analyses to examine correlations
between analytes and to compare BDE-47
body burdens among groups and by age were
performed using STATA 7 (Stata Corp.,
College Station, TX).
Results
Serum and adipose samples from all three
studies (Petreas et al. 2000, 2002; Windham et
al. 2002) were originally scheduled for analysis
of PCBs and OCPs (She at al. 1997), with the
PBDEs added on as a secondary objective after
analytical methods were developed. Only 1 mL
of serum was available for analysis, limiting our
ability to detect low levels. Therefore, only
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Table 1. Demographic characteristics of the three groups of California women. 
Group Breast cancer Reproductive (Laotian) Child development
No. 32 50 420
Years sampled 1996–1998 1997–1999 1959–1967
Age (years)
Mean ± SD 47.4 ± 7.7 31.4 ± 6.2 26.8 ± 6.2
Median (range) 48 (28–62) 32 (19–40) 26 (15–44)
Race (%)
White 62.5 0 63.6
African American 25.0 0 26.4
Asian 12.5 100 4.1
U.S. born (%) 84.4 0 79.0
Prior pregnancy (%) 75 88 56a
aAll participants in this group were pregnant during blood draw; value refers to previous pregnancy.BDE-47 could be measured in serum without
interference from the blank (signal in the sam-
ple should be at least 3× the signal in the
blank), resulting in a much higher reporting
limit for BDE-47 in serum (10 ng/g lipid)
than in adipose tissue (< 0.5 ng/g lipid).
BDE-47 was the major congener in adipose
samples, and BDE-99, BDE-100, BDE-153,
and BDE-154 were also measurable in all adi-
pose samples. Table 1 shows demographic
characteristics and Table 2 shows concentra-
tions of BDE-47 and PCB-153 in the three
groups of California women.
As shown in Table 1, the 32 women in
the breast cancer subsample examined here
were 28–62 years of age; most (84.4%) were
born in the United States, and 62.5% were
white. More than 95% had a college educa-
tion, and 75% had at least one prior birth. Of
the immigrant group, most participants were
born in Laos, where they had spent the first
part of their lives (mean ± SD, 11.8 ± 6.1
years), and had immigrated to the United
States within the previous 2–20 years (14.4 ±
4.5 years), after various lengths of time (5.4 ±
4.8 years) in Thailand, presumably in refugee
camps. Half the women had only an elemen-
tary school level education, and 18% had
completed high school; most (88%) had a
prior pregnancy. Among the women from the
CHDS, the age ranged from 15 to 44 years
(Table 1); 56% had one or more prior preg-
nancies, and 56% had graduated from high
school and 14% from college. Most women
were white (63.6%) or African American
(26.4%). About 79% were born in the
United States, 9.3% were foreign born (about
2% were born in Asia), and the birthplace was
unknown for 11.7%.
We analyzed 32 adipose samples and 50
serum samples from the late 1990s and 420
serum samples from the 1960s. All samples
were analyzed individually. We had no coelu-
tions on the DB-XLB column with any PCB
or OCP expected in human serum (James et al.
2002). Recoveries of internal standards (PCB
congeners 14, 65, and 166 and TCMX) were
used to gauge overall data quality for all ana-
lytes across all serum batches. Recoveries were
between 81% and 99%, and no corrections
were made to the measurements. In addition,
BDE-47 recoveries in fortified bovine serum
included with every batch were between 93%
and 113%.
As shown in Table 2, BDE-47 was meas-
urable in all adipose samples (100% above the
reporting limit), with concentrations ranging
from 5.2 ng/g lipid to 196 ng/g lipid, and a
mean of 28.9 ng/g lipid. Concentrations in
the 1990s serum ranged from < 10 ng/g lipid
(reporting limit) to 511 ng/g lipid, with a
mean of 50.6 ng/g lipid (median, 16.5 ng/g
lipid). Summary statistics were calculated
using the reporting limit for all samples at or
below that limit. BDE-47 was not measurable
in any of the 1960s serum samples. Despite
the limitation of an elevated reporting limit, it
is clear that none of the 420 serum samples
from the early 1960s contained BDE-47
above the reporting limit of 10 ng/g lipid,
whereas BDE-47 was measurable in 24 of the
50 serum samples from the late 1990s with
the same reporting limit. PCB-153 was mea-
surable in all specimens (adipose and serum)
from all three groups of women (Table 2).
The Spearman correlation coefficient (r)
between BDE-47 concentrations and age for
the 32 mostly U.S.-born women (adipose
samples) was r = –0.413 (p = 0.019), indicat-
ing a signiﬁcant negative association. The cor-
relation was not signiﬁcant for the 50 Laotian
serum samples (r = 0.079, p = 0.589) or for
the two 1990s groups combined (r = 0.058,
p = 0.606). In contrast, for the same two
1990s groups, a significant correlation was
found for PCB-153 and age (r = 0.619,
p < 0.001). No correlation was found between
BDE-47 and PCB-153 (r = 0.062, p = 0.647)
for the same two groups of women combined.
Discussion
Noren and Meironyte (1998) reported that
concentrations of PBDEs (BDE-28, BDE-47,
BDE-66, BDE-85, BDE-99, BDE-100,
BDE-153, and BDE-154) in human milk
from Sweden were increasing exponentially
over time. Several reports on PBDEs in biota
followed (Alaee et al. 1999; Darnerud et al.
1998; de Boer et al. 1998; Ryan and Patry
2000; Schroeter-Kermani et al. 2000), includ-
ing ours (She et al. 2000, 2002), which
showed an exponential increase of BDE-47,
BDE-99, BDE-100, BDE-153, and BDE-154
in archived blubber from San Francisco Bay
harbor seals. In the same study, we reported
high concentrations of BDE-47, BDE-99,
BDE-100, BDE-153, and BDE-154 in adi-
pose tissues collected from San Francisco Bay
Area women in the late 1990s. BDE-47 was
the dominant PBDE congener in all of our
samples, in agreement with other human stud-
ies. Because our current work focuses on
BDE-47, we will limit our discussion to that
congener in our comparisons with other stud-
ies. Soon after our ﬁrst study (She et al. 2000),
a single composite human milk sample col-
lected in 2000 from the United States showed
high concentrations of several BDE congeners,
including BDE-47 (120 ng/g lipid) (Papke et
al. 2001), confirming our finding that U.S.
levels appeared higher than levels reported in
European studies, whose averages ranged
within 1–10 ng/g lipid (Darnerud et al. 1998;
Noren and Meironyte 2000; Schroeter-
Kermani et al. 2000; Thomsen et al. 2002;
van Bavel et al. 2002). Conversely, when 12
serum samples collected in 1988 at an Illinois
blood bank were analyzed for PBDEs, the
median concentration of BDE-47 was 0.6
ng/g lipid, with a range of < 0.4–24 ng/g lipid
(Sjodin et al. 2001). According to the authors,
these 1988 U.S. levels were considered equiva-
lent to levels measured in Swedish blood col-
lected in 1995 (Sjodin et al. 2001). When we
compare these 1988 Illinois serum concentra-
tions (Sjodin et al. 2001) with those we
reported in our 1996–1998 California adipose
samples (She at al. 2002) and in the composite
milk sample (Papke et al. 2001), we can see an
increase in U.S. body burdens of BDE-47 over
the last 10–15 years. Our newest data support
this observation. As shown in Table 2, con-
centrations of BDE-47 were below the report-
ing limit (10 ng/g lipid) in all the serum
samples from the 1960s, whereas concentra-
tions in 1990s adipose tissues averaged 28.9
ng/g lipid (median, 16.5 ng/g lipid), and con-
centrations in the late 1990s serum averaged
50.6 ng/g lipid (median, 10 ng/g lipid). A
similar increase has been reported for human
milk from Canada, where median PBDE lev-
els have increased from 1.7 ng/g lipid in 1992
to 25.4 ng/g lipid in 2001 (Ryan et al. 2002).
Although differences in PBDE partitioning in
the various matrices examined (adipose,
serum, milk) may confound precise compar-
isons, it is clear that for samples collected in
the 1990s from the United States and
Canada, body burdens are 3–10 times higher
than those reported from Europe (Darnerud
et al. 1998; Noren and Meironyte 2000;
Schroeter-Kermani et al. 2000; Thomsen et
al. 2002; van Bavel et al. 2002) or Japan
(Ohta et al. 2002). This observation may be
consistent with California regulations man-
dating that all polyurethane foam and textiles
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Table 2. Concentrations of BDE-47 and PCB-153 in the three groups of California women.
Group Breast cancer Reproductive (Laotian) Child development
No. 32 50 420
Years sampled 1996–1998 1997–1999 1959–1967
Matrix Breast adipose Serum Serum
PBDE-47 (ng/g lipid)
Percent > reporting limit 100% 48% 0%
Mean ± SD 28.9 ± 39.8 50.6 ± 94.6 —
Median (range) 16.5 (5.2–196) 10 (< 10–511) < 10
PCB-153 (ng/g lipid)
Percent > reporting limit 100% 100% 100%
Mean ± SD 158.8 ± 68.5 52.7 ± 38.3 82.9 ± 43.8
Median (range) 157.9 (61–321) 41.2 (5.6–195) 72.5 (7–409)used in furnishings pass a flammability test
(not necessarily requiring use of PBDEs)
(State of California 1991, 2000). It is possible
that these unique California regulations drive
the consumer product market across the
United States and, perhaps, Canada. Regional
differences have also been reported in sewage
sludge, where PBDE concentrations appeared
10 times higher in the United States than in
Europe (Hale et al. 2001, 2002).
The Laotian immigrant women in this
study had much higher dichlorodiphenyl-
dichloroethylene (DDE) and dichlorodiphenyl-
trichloroethane (DDT) concentrations (as
expected) and quite lower PCB levels in their
serum than those measured in the adipose tissue
of the mostly U.S.-born women sampled in the
same period (Petreas et al. 2002; Windham et
al. 2002). It is therefore noteworthy that the
Laotians showed serum BDE-47 concentra-
tions equivalent to (or even greater than) adi-
pose concentrations of the contemporary group
that was mostly born in the United States. We
should note, however, that comparing these
two groups is complicated for several reasons:
not only are we comparing serum with adi-
pose levels but we are also comparing women
of different ages who were born and raised in
different continents with different lifestyles.
Although we are not familiar with blood/
adipose partition coefﬁcients for PBDEs, it is
well established that, for most POPs, lipid-
adjusted concentrations in serum and adipose
tissue are not exactly the same (Archibeque-
Engle et al. 1997; Lopez-Carrillo et al. 1999;
Mussalo-Rauhama 1991; Needham et al.
1990). As shown in Figure 1, there is little age
overlap between the two study populations,
and the younger Laotian women appear to
have higher and more variable levels of
BDE-47 than do the older, mostly U.S.-born
women. Because penta-BDE formulations are
not widely used in Asia (BSEF 2001), it seems
unlikely that these Laotian women were
exposed in Laos or in the Thai refugee camps.
Thus, it is more likely that practices and
lifestyles acquired more recently in the United
States are the main exposure pathways. Fish
consumption was one of the eligibility criteria
for the Laotian women; therefore, this is
another source of exposure that may differ
from the other populations. These Laotian
women consumed ﬁsh from the San Francisco
Bay in amounts similar to those of an earlier
study of anglers ﬁshing in the bay [California
Department of Health Services (CDHS)
2001)]. Although we do not have data on
PBDE levels in bay ﬁsh, we have reported an
exponential increase in PBDEs in harbor seals
(She et al. 2002) from the San Francisco Bay.
In addition, there are fish advisories recom-
mending limited bay fish consumption
because of contamination with PCBs and
mercury. Similar to PCBs, PBDEs would be
expected to accumulate in fatty fish. The
angler report (CDHS 2001) noted that Asians
are more likely than other ethnic groups to
prepare and consume ﬁsh in a manner that is
likely to increase their exposure to contami-
nants. Almost all of the Laotian women con-
sumed at least some marine fish, compared
with about 30% of the U.S. population (U.S.
EPA 1997). On the other hand, given the rel-
atively low PCB body burdens in our Laotian
women, fish consumption could not be a
major pathway for PBDEs. At this time, we
can only speculate on possible explanations for
these differences, including different activities
or lifestyle factors affecting exposure, age
effects on metabolic clearance of BDE-47, or
greater BDE-47 partitioning in serum than in
adipose tissue.
A lack of a signiﬁcant increase with age, in
contrast to other POPs, has been reported for
PBDEs (Darnerud et al. 1998; Thomsen et al.
2002), and our data appear to support this.
The correlation between BDE-47 and age was
not significant for both groups combined.
When we examined the two groups separately,
the correlation was similarly not signiﬁcant for
serum alone, but a signiﬁcant negative correla-
tion in the adipose was seen. Thomsen et al.
(2002) reported higher PBDE concentrations
in young children compared with other age
groups in Norway, but no differences among
age groups corresponding to those seen in our
study. We had reported higher ΣPBDE con-
centrations (p < 0.05) in the adipose of women
younger than 48 years (median age) compared
with those older than 48 years in a subset of 23
women (She at al. 2002). Expanding the sam-
ple size to 32 women retained the difference
between young and old and revealed this sig-
niﬁcant inverse correlation with age. Given the
small number of samples, however, and the
presence of outliers, this association may be
spurious. Regardless, the important ﬁnding is
that the association between BDE-47 and age
is not positive, a departure from other POPs.
When we examined the two 1990s groups of
women combined, the concentration of
PCB-153 (the most prominent PCB con-
gener in humans) increased with age. On the
other hand, there was no correlation between
BDE-47 and PCB-153 concentrations in our
samples, possibly indicating different expo-
sure pathways for BDE-47 from those for
other POPs, which are driven by diet. A
strong possibility is inhalation or ingestion of
indoor air dust from PBDE-treated consumer
products, particularly polyurethane foam.
PBDEs have been reported in dust collected
with vacuum cleaners from European ofﬁces
(Leonards et al. 2001) and homes (Knoth et
al. 2002). Although BDE-209 was the domi-
nant congener in office and house dust,
BDE-47 was also present, ranking second or
third in concentration.
Our data indicate the presence of outliers.
These high BDE-47 values did not parallel
high levels of PCBs or pesticides measured in
the same samples (Petreas et al. 2002). High
BDE-47 levels were not explained by any of
the common POPs predictors such as age,
parity, lactation, occupation, country of birth,
socioeconomic status, or medical history.
Because the study questionnaires were not
designed to assess PBDE exposures, questions
that might elucidate exposure pathways were
not included. Outliers in PBDE distributions
have also been reported recently for Swedish
blood (van Bavel et al. 2002) and Canadian
milk (Ryan et al. 2002). It is possible that
these outliers reflect hot spots originating
from the relatively recent introduction of
PBDEs and its still inconsistent presence in
the food web, as well as from the selective use
of various PBDE-treated consumer products.
Our analysis showed the emergence of
BDE-47 in residents of the San Francisco Bay
Area by the late 1990s, compared with the
1960s, conﬁrming similar trends from Canada
(Ryan et al. 2002), Germany (Schroeter-
Kermani et al. 2000), Sweden (Noren and
Meironyte 1998, 2000), and Norway
(Thomsen et al. 2002). Our study has several
weaknesses stemming from the fact that the
three epidemiologic studies we used were not
designed to assess PBDE exposures. Sample
volumes were small, raising the reporting level
and limiting the numbers of detectable sam-
ples, which in turn did not allow analysis of
subgroups at higher risk of exposure. In addi-
tion, only the most dominant PBDE,
BDE-47, could be measured in the serum
samples, precluding analysis of PBDE proﬁles.
Nevertheless, BDE-47 concentrations were
high, pointing to the need for follow-up stud-
ies designed to investigate PBDE exposures.
Increasing body burdens, particularly in young
women of reproductive age, pose a potential
public health threat to future generations.
PBDE sources need to be recognized, evalu-
ated, and controlled to minimize exposures. At
the same time, the systematic monitoring of
Article | Petreas et al.
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Figure 1. BDE-47 concentrations (ng/g lipid) in
serum samples from Laotian women and adipose
samples from mostly U.S.-born women. All samples








































































●body burdens of known and emerging POPs
should become a high priority for our public
health system (Hooper and McDonald 2000).
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